Bilgin Osmanodja

1.1k total citations
40 papers, 444 citations indexed

About

Bilgin Osmanodja is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Bilgin Osmanodja has authored 40 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Transplantation, 14 papers in Surgery and 8 papers in Nephrology. Recurrent topics in Bilgin Osmanodja's work include Renal Transplantation Outcomes and Treatments (20 papers), Transplantation: Methods and Outcomes (8 papers) and Renal Diseases and Glomerulopathies (7 papers). Bilgin Osmanodja is often cited by papers focused on Renal Transplantation Outcomes and Treatments (20 papers), Transplantation: Methods and Outcomes (8 papers) and Renal Diseases and Glomerulopathies (7 papers). Bilgin Osmanodja collaborates with scholars based in Germany, Austria and Australia. Bilgin Osmanodja's co-authors include Klemens Budde, Eva Schrezenmeier, Fabian Halleck, Wiebke Duettmann, Manuel Mayrdorfer, Marcel G. Naik, Julia Beck, Ekkehard Schütz, Michael Oellerich and Lutz Liefeldt and has published in prestigious journals such as PLoS ONE, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Bilgin Osmanodja

34 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bilgin Osmanodja Germany 12 242 161 98 87 57 40 444
Rachel Hellemans Belgium 12 246 1.0× 160 1.0× 53 0.5× 91 1.0× 49 0.9× 37 390
Fatemeh Pour-Reza-Gholi Iran 13 190 0.8× 120 0.7× 86 0.9× 111 1.3× 39 0.7× 28 445
W. James Chon United States 14 227 0.9× 150 0.9× 99 1.0× 118 1.4× 46 0.8× 23 663
Anna Faura Spain 11 122 0.5× 92 0.6× 69 0.7× 36 0.4× 65 1.1× 26 389
Erik L. Lum United States 12 187 0.8× 124 0.8× 57 0.6× 73 0.8× 39 0.7× 48 387
Lúcio Requião‐Moura Brazil 12 137 0.6× 87 0.5× 50 0.5× 77 0.9× 98 1.7× 51 361
Tainá Veras de Sandes‐Freitas Brazil 10 237 1.0× 158 1.0× 62 0.6× 145 1.7× 58 1.0× 46 400
A.E Bittar Brazil 14 212 0.9× 144 0.9× 56 0.6× 119 1.4× 33 0.6× 37 499
Maria Ajaimy United States 13 363 1.5× 181 1.1× 124 1.3× 88 1.0× 102 1.8× 33 553
Samir J. Patel United States 9 263 1.1× 140 0.9× 26 0.3× 49 0.6× 59 1.0× 19 390

Countries citing papers authored by Bilgin Osmanodja

Since Specialization
Citations

This map shows the geographic impact of Bilgin Osmanodja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bilgin Osmanodja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bilgin Osmanodja more than expected).

Fields of papers citing papers by Bilgin Osmanodja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bilgin Osmanodja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bilgin Osmanodja. The network helps show where Bilgin Osmanodja may publish in the future.

Co-authorship network of co-authors of Bilgin Osmanodja

This figure shows the co-authorship network connecting the top 25 collaborators of Bilgin Osmanodja. A scholar is included among the top collaborators of Bilgin Osmanodja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bilgin Osmanodja. Bilgin Osmanodja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rincón-Arévalo, Héctor, Bilgin Osmanodja, Annika Wiedemann, et al.. (2025). Soluble checkpoint molecules as predictive biomarker for disease activity and long-term outcome in SLE. Frontiers in Immunology. 16. 1685275–1685275.
2.
Roller, Roland, Bilgin Osmanodja, Aljoscha Burchardt, et al.. (2025). Human-centered AI in healthcare: empowering patients and support persons in clinical decision-making. BMC Medical Informatics and Decision Making. 25(1). 431–431.
3.
Dittmayer, Carsten, Duygu Elif Yılmaz, Michael Mülleder, et al.. (2024). Immunosuppression with cyclosporine versus tacrolimus shows distinctive nephrotoxicity profiles within renal compartments. Acta Physiologica. 240(8). e14190–e14190. 7 indexed citations
4.
Budde, Klemens, Michael Oellerich, Julia Beck, et al.. (2024). Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical Implications. Transplant International. 37. 13239–13239. 1 indexed citations
5.
6.
Osmanodja, Bilgin, Roland Roller, Aljoscha Burchardt, et al.. (2024). Investigating the Impact of AI on Shared Decision-Making in Post-Kidney Transplant Care (PRIMA-AI): Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 13. e54857–e54857. 2 indexed citations
7.
8.
9.
Osmanodja, Bilgin, Klemens Budde, Michael Oellerich, et al.. (2024). Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series. Transplant International. 37. 13213–13213. 4 indexed citations
10.
Budde, Klemens, Mira Choi, Michael Oellerich, et al.. (2023). Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation. Kidney International Reports. 8(10). 2141–2145. 2 indexed citations
11.
Budde, Klemens, Fabian Halleck, Georgios K. Eleftheriadis, et al.. (2023). COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center. Journal of Clinical Medicine. 12(18). 6103–6103. 1 indexed citations
12.
Beck, Susanne, Klemens Budde, Aljoscha Burchardt, et al.. (2023). Klinische Entscheidungsfindung mit Künstlicher Intelligenz. Essentials. 7 indexed citations
13.
Osmanodja, Bilgin, Michael Oellerich, Julia Beck, et al.. (2023). Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study. Journal of Clinical Medicine. 12(6). 2437–2437. 5 indexed citations
14.
15.
Roller, Roland, Aljoscha Burchardt, Simon Ronicke, et al.. (2023). When performance is not enough—A multidisciplinary view on clinical decision support. PLoS ONE. 18(4). e0282619–e0282619. 4 indexed citations
16.
Oellerich, Michael, Klemens Budde, Bilgin Osmanodja, et al.. (2022). Donor-derived cell-free DNA as a diagnostic tool in transplantation. Frontiers in Genetics. 13. 1031894–1031894. 46 indexed citations
17.
Osmanodja, Bilgin, Johannes Stegbauer, Lars Christian Rump, et al.. (2022). Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients. Frontiers in Immunology. 13. 997343–997343. 9 indexed citations
18.
Roller, Roland, Manuel Mayrdorfer, Wiebke Duettmann, et al.. (2022). Evaluation of a clinical decision support system for detection of patients at risk after kidney transplantation. Frontiers in Public Health. 10. 979448–979448. 15 indexed citations
19.
Roller, Roland, Patrik Hummel, Bilgin Osmanodja, et al.. (2022). “Nothing works without the doctor:” Physicians’ perception of clinical decision-making and artificial intelligence. Frontiers in Medicine. 9. 1016366–1016366. 14 indexed citations
20.
Wu, Kaiyin, Danilo Schmidt, Bilgin Osmanodja, et al.. (2022). Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions. Frontiers in Medicine. 9. 889648–889648. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Hellemans Breakdown of academic impact, for papers by Fatemeh Pour-Reza-Gholi Breakdown of academic impact, for papers by W. James Chon Breakdown of academic impact, for papers by Anna Faura Breakdown of academic impact, for papers by Erik L. Lum Breakdown of academic impact, for papers by Lúcio Requião‐Moura Breakdown of academic impact, for papers by Tainá Veras de Sandes‐Freitas Breakdown of academic impact, for papers by A.E Bittar Breakdown of academic impact, for papers by Maria Ajaimy Breakdown of academic impact, for papers by Samir J. Patel
Rankless by CCL
2026